QuantCapitol. Congressional Trading Intelligence

Updated 2026-11-05 08:10 UTC · Public disclosure record

AXTATICKER

Axalta Coating Systems Ltd.

INSUFFICIENT DATA stock

Congress has disclosed 4 buys and 15 sells of AXTA (Axalta Coating Systems Ltd.) in official financial disclosures, each linked to its original filing. A transparency record — not investment advice.

Activity Congressional Activity

4
Buy
15
Sell
-11
Net
2
Active politicians
Price & congressional trades
Buy Sell

Fundamentals · FY2026 Valuation

Standard valuation multiples from SEC-reported GAAP financials (trailing twelve months), each compared to the median for —. We use reported GAAP, not forward or adjusted earnings, so our figures can sit higher than sites that do — especially for companies with falling profit. Relative context — not a target price or investment advice.

P/E
21.83
no sector median
how it's calculated
P/E = price ÷ earnings per share
$34.07 ÷ $1.56 = 21.83
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
P/B
2.78
no sector median
how it's calculated
P/B = price ÷ book value per share
$34.07 ÷ $12.24 = 2.78
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
EV/EBITDA
11.06
no sector median
how it's calculated
EV/EBITDA = (market cap + net debt) ÷ EBITDA
($7.3B + $3.0B net debt) ÷ $0.9B = $10.3B ÷ $0.9B = 11.06
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.

19 trades Recent Congressional Trades

Two things to watch per trade: the disclosure lag (how many days passed before the trade was made public) and the price move in that window (how the stock moved during those non-public days). A sell followed by a price drop, or a buy followed by a rise, means well-timed trading — visible here in the open. Note: the Score measures how notable a trade is, not whether it made money — the price move is shown for context and isn't part of it.

PoliticianChamberTypeOwnerDateDisclosure lagPrice move
in that
window
AmountScoreSource
Rohit Khanna House SELL OCR Child 2026-05-27 12 days +5.0% $1K–$15K 11.7 ↗ filing
Rohit Khanna House SELL OCR Child 2026-05-26 13 days +6.1% $1K–$15K 11.6 ↗ filing
Rohit Khanna House SELL OCR Child 2026-02-23 9 days -7.8% $1K–$15K 6.0 ↗ filing
Rohit Khanna House SELL OCR Child 2026-02-17 15 days -10.2% $1K–$15K 5.1 ↗ filing
Rohit Khanna House SELL OCR Child 2026-02-12 20 days -7.1% $1K–$15K 5.1 ↗ filing
Rohit Khanna House SELL OCR Child 2026-02-04 28 days -8.4% $1K–$15K 5.0 ↗ filing
Rohit Khanna House SELL OCR Child 2026-02-03 29 days -2.7% $1K–$15K 5.0 ↗ filing
Rohit Khanna House BUY OCR Child 2025-10-29 6 days -6.5% $1K–$15K 4.0 ↗ filing
Rohit Khanna House BUY OCR Child 2025-10-28 7 days -7.2% $1K–$15K 4.9 ↗ filing
Rohit Khanna House BUY OCR ◆ insider divergence Child 2025-08-22 13 days -1.9% $1K–$15K 6.1 ↗ filing
Rohit Khanna House SELL OCR ◆ insider convergence Child 2025-02-04 29 days -7.0% $1K–$15K 6.8 ↗ filing
Rohit Khanna House SELL OCR Child 2024-11-12 22 days +2.5% $1K–$15K 8.6 ↗ filing
John James House SELL Self · John A. James Children’s Trust 2024-05-06 113 days — $1K–$15K
<0.1% of NW
26.0 ↗ filing
John James House BUY ◆ insider convergence · moderate Self · John A. James Children’s Trust 2023-11-10 277 days — $1K–$15K
<0.1% of NW
75.9 ↗ filing
Rohit Khanna House SELL OCR ◆ insider divergence · strong Child 2023-08-01 35 days — $1K–$15K 10.6 ↗ filing
Rohit Khanna House SELL OCR ◆ insider divergence · strong Child 2023-07-21 11 days — $1K–$15K 15.7 ↗ filing
Rohit Khanna House SELL OCR ◆ insider divergence · strong Child 2023-07-12 20 days — $1K–$15K 22.3 ↗ filing
Rohit Khanna House SELL OCR ◆ insider divergence · strong Child 2023-04-28 5 days — $1K–$15K 40.4 ↗ filing
Rohit Khanna House SELL OCR ◆ insider divergence · strong Child 2023-04-03 30 days — $1K–$15K 75.9 ↗ filing

Corporate insiders · SEC Form 4 Insider Activity

What the company's own officers and directors did in AXTA — open-market purchases and sales from SEC Form 4 filings (option exercises, grants and tax withholding are excluded). This is context for the congressional activity above, never a buy/sell signal, and the two datasets are kept separate on purpose. Does convergence mean anything? →

2
Congress trades with insider convergence
6
…with insider divergence
13
Insider open-market trades

Of the congressional trades in AXTA, 2 coincided with corporate insiders moving the same way within 60 days, and 6 with insiders moving the opposite way. This is co-occurrence only — whether it carries any edge is tested honestly on the convergence page.

DateInsiderRoleTypeSizeSource
2025-08-19 Tufano Amy Other SELL $99K ↗ EDGAR
2025-02-10 Weaver Troy D. C-suite SELL $393K ↗ EDGAR
2023-12-04 Awada Hadi Other SELL $336K ↗ EDGAR
2023-11-17 BERUBE BRIAN A Other SELL $234K ↗ EDGAR
2023-11-14 Massey Anthony Other SELL $553K ↗ EDGAR
2023-11-09 MCLAUGHLIN ROBERT M Director SELL $149K ↗ EDGAR
2023-09-13 Kissire Deborah J. Director BUY $11K ↗ EDGAR
2023-09-12 COOK WILLIAM M Director BUY $40K ↗ EDGAR
2023-09-06 Stein Kevin M Director BUY $1.0M ↗ EDGAR
2023-08-09 Scanlan Jacqueline Other SELL $501K ↗ EDGAR
2023-08-04 Villavarayan Chris C-suite BUY $1.0M ↗ EDGAR
2023-03-14 COOK WILLIAM M Director BUY $74K ↗ EDGAR
2023-03-13 Villavarayan Chris C-suite BUY $1.0M ↗ EDGAR

Combined timeline — Congress & insiders

Both sets of trades on one timeline, newest first, so you can see when they lined up. Congress vs ◆ insider.

DateWhoTypeSize
Congress 2026-05-27 Rohit Khanna SELL $1K–$15K
Congress 2026-05-26 Rohit Khanna SELL $1K–$15K
Congress 2026-02-23 Rohit Khanna SELL $1K–$15K
Congress 2026-02-17 Rohit Khanna SELL $1K–$15K
Congress 2026-02-12 Rohit Khanna SELL $1K–$15K
Congress 2026-02-04 Rohit Khanna SELL $1K–$15K
Congress 2026-02-03 Rohit Khanna SELL $1K–$15K
Congress 2025-10-29 Rohit Khanna BUY $1K–$15K
Congress 2025-10-28 Rohit Khanna BUY $1K–$15K
Congress 2025-08-22 Rohit Khanna BUY $1K–$15K
◆ insider 2025-08-19 Tufano Amy Other SELL $99K
◆ insider 2025-02-10 Weaver Troy D. C-suite SELL $393K
Congress 2025-02-04 Rohit Khanna SELL $1K–$15K
Congress 2024-11-12 Rohit Khanna SELL $1K–$15K
Congress 2024-05-06 John James SELL $1K–$15K
◆ insider 2023-12-04 Awada Hadi Other SELL $336K
◆ insider 2023-11-17 BERUBE BRIAN A Other SELL $234K
◆ insider 2023-11-14 Massey Anthony Other SELL $553K
Congress 2023-11-10 John James BUY $1K–$15K
◆ insider 2023-11-09 MCLAUGHLIN ROBERT M Director SELL $149K
◆ insider 2023-09-13 Kissire Deborah J. Director BUY $11K
◆ insider 2023-09-12 COOK WILLIAM M Director BUY $40K
◆ insider 2023-09-06 Stein Kevin M Director BUY $1.0M
◆ insider 2023-08-09 Scanlan Jacqueline Other SELL $501K

FAQ Common questions

How much has Congress traded AXTA?

4 disclosed buys and 15 sells of AXTA (Axalta Coating Systems Ltd.) appear in official congressional financial disclosures.

Is it legal for members of Congress to trade AXTA?

Members of Congress may trade stocks but must disclose it under the STOCK Act. QuantCapitol tracks those public disclosures for transparency — nothing here is an accusation of wrongdoing or investment advice.

Where does this data come from?

Official US House Clerk and Senate electronic financial disclosures. Every trade links back to its original filing so you can verify it yourself.

About this data. Sourced from official House Clerk and Senate eFD financial disclosures (Senate via a maintained community mirror — see project documentation). Transaction amounts are reported as ranges, not exact figures. Interest scores, consensus labels, and backtested performance are proprietary analytical calculations based on public data and are not investment advice. Backtested performance is a hypothetical simulation, not actual portfolio performance.